Tags

Type your tag names separated by a space and hit enter

Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment.

Abstract

There are frequent advances in knowledge about the clinical presentation, pathophysiology, and treatment of irritable bowel syndrome. It is important for clinicians to be aware of available therapies and the supporting evidence for those therapies to increase patient satisfaction. This is best achieved with a collaborative and long-term clinician-patient relationship and mutual commitment to modify therapy and try new modalities until the greatest relief of symptoms and improvement in health-related quality of life is achieved. This article reviews symptoms, comorbidities, gender differences, and measure of severity in irritable bowel syndrome and current and evidence-based approaches to evaluation and treatment, and the new symptom-based Rome III diagnostic criteria are reviewed and explained.

Links

  • Publisher Full Text
  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Center for Neurovisceral Sciences and Women's Health, Division of Digestive Diseases, David Geffen School of Medicine at UCLA and VA Greater Los Angeles Healthcare System, CURE Building 115, Room 223, 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA.

    Source

    MeSH

    Anti-Infective Agents
    Antidepressive Agents
    Antidiarrheals
    Biomarkers
    Colonoscopy
    Complementary Therapies
    Humans
    Incidence
    Irritable Bowel Syndrome
    Laxatives
    Prognosis
    Risk Factors
    Sex Factors

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    17950443

    Citation

    Videlock, Elizabeth J., and Lin Chang. "Irritable Bowel Syndrome: Current Approach to Symptoms, Evaluation, and Treatment." Gastroenterology Clinics of North America, vol. 36, no. 3, 2007, pp. 665-85, x.
    Videlock EJ, Chang L. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol Clin North Am. 2007;36(3):665-85, x.
    Videlock, E. J., & Chang, L. (2007). Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterology Clinics of North America, 36(3), pp. 665-85, x.
    Videlock EJ, Chang L. Irritable Bowel Syndrome: Current Approach to Symptoms, Evaluation, and Treatment. Gastroenterol Clin North Am. 2007;36(3):665-85, x. PubMed PMID: 17950443.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. AU - Videlock,Elizabeth J, AU - Chang,Lin, PY - 2007/10/24/pubmed PY - 2008/1/18/medline PY - 2007/10/24/entrez SP - 665-85, x JF - Gastroenterology clinics of North America JO - Gastroenterol. Clin. North Am. VL - 36 IS - 3 N2 - There are frequent advances in knowledge about the clinical presentation, pathophysiology, and treatment of irritable bowel syndrome. It is important for clinicians to be aware of available therapies and the supporting evidence for those therapies to increase patient satisfaction. This is best achieved with a collaborative and long-term clinician-patient relationship and mutual commitment to modify therapy and try new modalities until the greatest relief of symptoms and improvement in health-related quality of life is achieved. This article reviews symptoms, comorbidities, gender differences, and measure of severity in irritable bowel syndrome and current and evidence-based approaches to evaluation and treatment, and the new symptom-based Rome III diagnostic criteria are reviewed and explained. SN - 0889-8553 UR - https://www.unboundmedicine.com/medline/citation/17950443/Irritable_bowel_syndrome:_current_approach_to_symptoms_evaluation_and_treatment_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0889-8553(07)00062-3 DB - PRIME DP - Unbound Medicine ER -